Stem Cell Cartilage Regeneration Market, By Stem Cell Type (Hematopoietic Stem Cells, Pluripotent Stem Cells, and Mesenchymal Stem Cells), By Treatment (Microfracture, Osteochondral Transplant, Autologous Chondrocyte Implantation, and Others), By End User (Hospitals & Clinics, and Ambulatory Surgical Centers), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

  • Published On : Jan 2019 |
  • Pages : 154 Pages |
  • Format : CMI Insight PPT Format CMI Insight PDF Format

Stem Cell Cartilage Regeneration Market – Insights

Stem cells therapy are emerging as an important therapeutic option in the field of cartilage regeneration. Rapid development of stem cell-based therapy for cartilage regeneration in the recent past has been witnessed across the world. Stem cells are mainly classified in three kinds of cells: hematopoietic stem cell, mesenchymal stem cells, and pluripotent stem cells.

The global stem cell cartilage regeneration market size was valued at US$ 254.4 million in 2017, and is expected to witness a CAGR of 8.9% over the forecast period (2018 – 2026).

Global Stem Cell Cartilage Regeneration Market Share (%) Analysis, By Stem Cell Type, 2017

Stem Cell Cartilage Regeneration  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2019)

Increasing Adoption of Minimally Invasive Surgery Procedures is expected to Drive Growth of Stem Cell Cartilage Regeneration Market

Stem cell therapy for knees, minimally invasive procedure, has the potential to decrease inflammation, halt progression of arthritic damage, repair joint cartilage, and delay or avoid knee replacement surgery. Injection of progenitor cells, especially mesenchymal stem cells (MSCs), has been found to be an effective and better solution for repairing degenerative cartilage compared to implantation of differentiated cells such as articular cartilage.

In addition to this, other potential benefits such as lower risk and shorter duration of minimally invasive surgery procedures are expected to fuel demand for stem cell therapy for cartilage regeneration during the forecast period. For instance, according to NCBI 2016 report, a minimally invasive procedure to harvest stem cells from both fat and bone marrow and inject the concentrated cells under image guidance can be performed in 2-3 hours.

Stem Cell Cartilage Regeneration Market Restraints

Stem cell therapy for cartilage damage is associated with high treatment costs. According to the Journal of Cell Science & Therapy 2017 article, stem cell therapy range from US$ 5,000 to US$ 8,000 per treatment. In the U.S., the one-time treatment, which utilizes blood drawn from a patient can cost as little as US$ 1,500. However, additional protocols that utilize a bone marrow or adipose tissue extraction for stem cells can cost as much as US$ 15,000 to US$ 30,000. Moreover, the bone marrow extraction is an invasive procedure, which requires bone penetration and adipose tissue extraction, necessitates a medical professional trained in liposuction. These challenges are expected to hamper the adoption of stem cell in cartilage regeneration, during the forecast period.

Stem Cell Cartilage Regeneration Market - Regional Insights

On the basis of region, the global stem cell cartilage regeneration market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is expected to be the most conducive region for growth of the stem cell cartilage regeneration market over the forecast period, due to high presence of key players in the region. Key players such as Vericel Corporation, Osiris Therapeutics, among others are focusing on various growth strategies such as gaining regulatory product approvals and launching innovative stem cell based cartilage regeneration products and technologies in the market.

Furthermore, increasing geriatric population, which is more prone to degenerative disorders such as osteoarthritis among the U.S. population, is further expected to propel growth of the stem cell cartilage regeneration market. For instance, according to Centers for Disease Control and Prevention (CDC), July 2018 data findings, from 2013-2015, an estimated 54.4 million U.S. adults (22.7% of total U.S. population) annually suffers from some form of arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia.

Asia Pacific stem cell cartilage regeneration market revenue is expected to significantly grow over the forecast period. In India, stem cell based cartilage regeneration procedures are conducted by various hospital and clinics. Hospitals such as Apollo, TOSH (Trauma & Orthopaedic Speciality Hospital), among others are conducting stem cell-based knee arthritis surgery procedures.

Global Stem Cell Cartilage Regeneration Market Value (US$ Mn) & Y-o-Y Growth (%); 2016-2026

   Stem Cell Cartilage Regeneration  | Coherent Market Insights

 Source: Coherent Market Insights Analysis (2019)

Stem Cell Cartilage Regeneration Market - Competitive Landscape

Key players operating in the global stem cell cartilage regeneration market include Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation.

In cartilage regeneration, stem cells have the potential for multiple differentiation and self-replication, making it an ideal choice for use as seed cells. Growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies are expected to drive growth of the market over the forecast period. Mesenchymal stem cells are the most widely applied stem cells in the field of cartilage regeneration.

Market Dynamics

Growing osteoarthritis incidence among the global population is supporting the adoption of stem cell cartilage regeneration therapy. For instance, according to November 2017, Arthritis Foundation data findings, with the increase in global geriatric population, degenerative disease disorders such as osteoarthritis will impact at least 130 million individuals around the globe by 2050.

Furthermore, various government agencies are focusing on policies to enhance adoption of stem cell therapies, which is expected to drive growth of stem cell cartilage regeneration market in the near future. For instance, in December 2016, the 21st Century Cures Act (Cures Act) was signed into law by the U.S. FDA, thereby allowing legislation for an expedited approval path for cellular medicines designated as regenerative medicine advanced therapies (RMATs) to patients who are in need of it.

However, high cost of treatment is expected to hamper the stem cell cartilage regeneration market during the forecast period. Moreover, extensive time and expertise required to perform stem cell based therapy leads to increase the cost of this procedure. In some cases, the physician must pay licensing fees to access stem cell sourcing, processing, or delivering these technologies.

Key features of the study:

  • This report provides in-depth analysis of the stem cell cartilage regeneration market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period (2018 – 2026), considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global stem cell cartilage regeneration market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global stem cell cartilage regeneration market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for stem cell cartilage regeneration market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

  • Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type:
    • Hematopoietic Stem Cells (HSCs)
    • Pluripotent Stem Cells (iPSC/ESCs)
    • Mesenchymal Stem Cells (MSCs)
  • Global Stem Cell Cartilage Regeneration Market, By Treatment:
    • Microfracture
    • Osteochondral Transplant
    • Autologous Chondrocyte Implantation
    • Stem Cell Injections
  • Global Stem Cell Cartilage Regeneration Market, By End User:
    • Hospitals & Clinics
    • Ambulatory Surgical Centers
  • Global Stem Cell Cartilage Regeneration Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Stem Cell Type:
        • Hematopoietic Stem Cells (HSCs)
        • Pluripotent Stem Cells (iPSC/ESCs)
        • Mesenchymal Stem Cells (MSCs)    
      • By Treatment:
        • Microfracture
        • Osteochondral Transplant
        • Autologous Chondrocyte Implantation
        • Stem Cell Injections
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Stem Cell Type:
        • Hematopoietic Stem Cells (HSCs)
        • Pluripotent Stem Cells (iPSC/ESCs)
        • Mesenchymal Stem Cells (MSCs)    
      • By Treatment:
        • Microfracture
        • Osteochondral Transplant
        • Autologous Chondrocyte Implantation
        • Stem Cell Injections
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Stem Cell Type:
        • Hematopoietic Stem Cells (HSCs)
        • Pluripotent Stem Cells (iPSC/ESCs)
        • Mesenchymal Stem Cells (MSCs)    
      • By Treatment:
        • Microfracture
        • Osteochondral Transplant
        • Autologous Chondrocyte Implantation
        • Stem Cell Injections
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Stem Cell Type:
        • Hematopoietic Stem Cells (HSCs)
        • Pluripotent Stem Cells (iPSC/ESCs)
        • Mesenchymal Stem Cells (MSCs)    
      • By Treatment:
        • Microfracture
        • Osteochondral Transplant
        • Autologous Chondrocyte Implantation
        • Stem Cell Injections
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Stem Cell Type:
        • Hematopoietic Stem Cells (HSCs)
        • Pluripotent Stem Cells (iPSC/ESCs)
        • Mesenchymal Stem Cells (MSCs)    
      • By Treatment:
        • Microfracture
        • Osteochondral Transplant
        • Autologous Chondrocyte Implantation
        • Stem Cell Injections
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
    • Africa
      • By Country:
        • South Africa
        • Central Africa
        • North Africa
      • By Stem Cell Type:
        • Hematopoietic Stem Cells (HSCs)
        • Pluripotent Stem Cells (iPSC/ESCs)
        • Mesenchymal Stem Cells (MSCs)    
      • By Treatment:
        • Microfracture
        • Osteochondral Transplant
        • Autologous Chondrocyte Implantation
        • Stem Cell Injections
      • By End User:
        • Hospitals & Clinics
        • Ambulatory Surgical Centers
  • Company Profiles
    • Theracell Advanced Biotechnology Ltd.*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Orthocell Ltd.
    • Xintela AB
    • CellGenix GmbH
    • Merck KGaA
    • Osiris Therapeutics, Inc.
    • BioTissue SA
    • Vericel Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objective and Assumption
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Overview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Stem Cell Type
      • Market Snippet, By Treatment
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Market Trends
    • Key Developments
    • Regulatory Landscape
    • PEST Analysis
  4. Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hematopoietic Stem Cells (HSCs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Pluripotent Stem Cells (iPSC/ESCs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Mesenchymal Stem Cells (MSCs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  5. Global Stem Cell Cartilage Regeneration Market, By Treatment, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Microfracture
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Osteochondral Transplant
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Autologous Chondrocyte Implantation
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Stem Cell Injections
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  6. Global Stem Cell Cartilage Regeneration Market, By End User, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, 2017 – 2026
      • Segment Trends
    • Hospitals & Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
    • Ambulatory Surgical Centers
      • Introduction  
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Million)
  7. Global Stem Cell Cartilage Regeneration Market, By Region, 2016 – 2026, (US$ Million)
    • Introduction
      • Market Share Analysis, By Region, 2018 and 2026 (%)
      • Y-o-Y Growth Analysis, By Region, 2017 – 2026
      • Regional Trends
    • North America
      • Market Size and Forecast, By Stem Cell Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast, By Stem Cell Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Stem Cell Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • China
        • Japan
        • India
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast, By Stem Cell Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Africa
      • Market Size and Forecast, By Stem Cell Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • North Africa
        • Central Africa
        • South Africa
    • Middle East
      • Market Size and Forecast, By Stem Cell Type, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Treatment, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By End User, 2016 – 2026, (US$ Million)
      • Market Size and Forecast, By Country, 2016 – 2026, (US$ Million)
        • GCC Countries
        • Israel
        • Rest of Middle East
  8. Competitive Landscape
    • Company Profiles
      • Theracell Advanced Biotechnology Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Orthocell Ltd.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Xintela AB
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • CellGenix GmbH
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Osiris Therapeutics, Inc.
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • BioTissue SA
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
      • Vericel Corporation
        • Company Overview
        • Product Portfolio
        • Financial Performance
        • Recent Highlights
        • Strategies
  9. Section
    • Analyst Views
    • References
    • Research Methodology
    • About Us and Sales Contact

*Browse 42 market data tables and 21 figures on "Stem Cell Cartilage Regeneration Market” - Global forecast to 2026”

Choose License Type

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

[email protected]

Key Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.